Results for tag: "Primary Biliary Cirrhosis Drug"

Primary Biliary Cirrhosis (PBC) is a chronic, progressive liver disease caused by the destruction of the bile ducts in the liver. It is a type of autoimmune disorder, in which the body's immune system mistakenly attacks healthy tissue. Treatment for PBC is aimed at slowing the progression of the disease and relieving symptoms. Liver and Kidney Disorders Drugs are used to treat PBC, including Ursodeoxycholic Acid (UDCA), corticosteroids, immunosuppressants, and other medications. UDCA is the most commonly prescribed drug for PBC, as it helps to reduce inflammation and improve bile flow. Corticosteroids and immunosuppressants are used to reduce inflammation and suppress the immune system. Other medications, such as vitamin D and calcium supplements, may be prescribed to help reduce symptoms. Companies in the Primary Biliary Cirrhosis Drug market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Show Less Read more